Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism

Pediatrics International

Volumn 41, Issue 3, 1999, Pages 266-269

  Asami, Tadashi ^a,b   Ciomartan, Tatiana ^a   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Congenital hypothyroidism; Intermediate low density lipoprotein; Thyroid hormones

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C2; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIOTHYRONINE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HYPOTHYROIDISM; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FREE THYROXINE INDEX; HORMONAL REGULATION; HUMAN; INFANT; LIOTHYRONINE BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CONGENITAL HYPOTHYROIDISM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; HYPOTHYROIDISM; INFANT; LIPASE; LIPOPROTEINS; LIPOPROTEINS, IDL; MALE; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIGLYCERIDES;

EID: 0033044908     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200x.1999.01067.x     Document Type: Article

References (20)

1. 1 Hansson P, Valdemarsson S, Nilsson-Ehle P. Experimental hyperthyroidism in man: Effects on plasma lipoproteins, lipoprotein lipase and hepatic lipase. Horm. Metab. Res. 1983; 15: 449-52.
2. 2 Valdemarsson S, Hedner P, Nilsson-Ehle P. Dyslipoproteinacmia in hypothyroidism of pituitary origin; effects of L-thyroxine substitution on lipoprotein lipase, hepatic lipase, and on plasma lipoproteins. Acta Endocrinol. 1983; 127: 192-7.
3. 3 Kuusi T, Taskinen MR, Nikkila EA. Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J. Clin. Endocrinol. Metab. 1988; 66: 51-6.
4. 4 Fong BS, Greco AV, Angel A. Hypothyroidism reduces HDL binding to rat liver cells. Atherosclerosis 1989; 79: 1-8.
5. 5 Asami T, Kikuchi T, Uchiyama M. Effects of L-thyroxine on serum lipid profiles in infants with congenital hypothyroidism. J. Pediatr. 1995; 127: 812-14.
6. 6 Christensen B, Glueck C, Kwiterovich P et al. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: The prevalence study of the lipid research clinics program Pediat. Res. 1980; 14: 194-202.
7. 7 Brenson GS, Srinivasan SR, Cresanta JL et al. Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation. Am. J. Epidemiol. 1981; 113: 157-70.
8. 8 Viikari J, Alerblom HK, Nikkari T et al. Atherosclerosis precursors in Finnish children and adolescents. IV. Serum lipids in newborns, children and adolescents. Acta Paediatr. Scand. (Suppl.) 1985; 318: 103-9.
9. 9 Bucher H, Rampini S, James RW et al. Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur. J. Pediatr. 1997; 156: 121-5.
10. 10 Naito HK, Wada M, Ehrhart LA et al. Polyacrylamide-gel-electrophoresis as a screening procedure for serum lipoprotein abnormalities. Clin. Chem. 1973; 19: 228-34.
11. 11 Muniz N. Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel. Clin. Chem. 1977; 23: 1826-33.
12. 12 Ballantyne FC, Epenetos AA, Caslake M et al. The composition of low density lipoprotein and very low density lipoprotein subfractions in primary hypothyroidism and the effect of hormone replacement therapy. Clin. Sci. 1979; 57: 83-8.
13. 13 Lisch HJ, Ogriseg M, Breier C et al. Concentration of the main lipoprotein density classes in disturbance of thyroid function in man. Klinische Wochenschrift 1979; 60: 337-42.
14. 14 Pagnan A, Casara D, Zanetti G et al. Serum lipids, "double pre-beta lipoproteinemia," and distribution of the apo-very-low density (VLDL) lipoprotein peptides in hypothyroid patients before and after substitution therapy. Metabolism 1980; 29: 1026-30.
15. 15 Packard CJ, Shepherd J, Lindsay GM et al. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J. Clin. Endocrinol. Metab. 1993; 76: 1209-16.
16. 16 Lithell M, Boberg J, Hellsing K et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein lipase activity in overt and subclinical hypothyroidism: The effect of substitution therapy. Eur. J. Clin. Invest. 1981; 11: 3-10.
17. 17 Valdemarsson S, Hedner P, Nilsson-Ehle P. Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism. Eur. J. Clin. Invest. 1982; 12: 423-8.
18. 18 Valdemarsson S, Hansson P, Hedner P et al. Relations between thyroid function, hepatic and lipoprotein lipase activities and plasma lipoprotein concentrations. Acta Endocrinol. 1983; 104: 50-6.
19. 19 Nozaki S, Shimomura I, Funahashi T et al. Stimulation of the activity and mRNA level of hepatic triacylglycerol lipase by triiodothyronine in HepG2 cells. Biochim. Biophys. Acta 1992; 1127: 298-302.
20. 20 Kihara S, Wolle J, Ehnholm C et al. Regulation of hepatic triglyceride lipase by thyroid hormone in HepG2 cells. J. Lipid Res. 1993; 34: 961-70.